Welcome! Defeating Merkel cell carcinoma begins here.
The critical first step is to find a Merkel cell carcinoma specialist.
It is critical that each case be reviewed by a multidisciplinary team, including surgical oncologists, radiation oncologists, medical oncologists, and dermatologists with significant experience in managing MCC, in order to develop a plan for the patient.
To find healthcare professionals experienced with Merkel cell carcinoma, start with our list of verified specialists.
Find a SpecialistMake sure your primary care team is knowledgeable and takes action.
Merkel cell carcinoma is rare, and it's common for many medical professionals to be unsure of where to start. When a diagnosis occurs, it is imperative that your medical team is knowledgeable and able to carry out an MCC specialist's plan.
Our clinical team recommends that all healthcare providers follow the NCCN guidelines for MCC to bring them up to speed on MCC and how to care for MCC patients.
Get the GuideConsider joining a patient-based group
A diagnosis of Merkel cell carcinoma is a life-changing experience. Support from others—in the form of advice, recommendations for local healthcare providers, or sharing personal victories—can help ease the burden many MCC patients and their families feel.
We encourage you to make connections; it’s been proven to help.
Get SupportThe latest advancements in treatment
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022
26 experts from 13 countries participated in writing these European guidelines that summarize optimal management of Merkel cell carcinoma. These recommendations replace a set of guidelines that was last published in 2015. The guidelines are designed to provide input on the management of all stages ...
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
This publication reflects expert opinion among experts in one country (Italy) as to optimal management of MCC. Although areas of controversy were identified as expected, there was high agreement that immune therapy for MCC makes sense in advanced cases, and that radiation therapy plays an important ...
Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma
The standard (“conventional”) way to give radiation for Merkel cell carcinoma (MCC) involves about 25 treatments given over a 5-week period. Because MCC patients are often older and may live quite far from a radiation therapy (RT) facility, a conventional course can be difficult to accomplish. F...